Free tool
FAERS Monitor: Acetaminophen
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018337 or its brand name (Acetaminophen, Acetaminophen). Reports on generic versions are filed under their own applications.
Reports
261,279
Serious
227,860
87% of reports
Hospitalization
117,813
Death reported
51,167
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use23,643
- fatigue21,355
- drug ineffective19,055
- pain18,805
- nausea18,668
- headache17,530
- toxicity to various agents16,856
- dyspnoea15,395
- vomiting14,905
- pyrexia14,843
- arthralgia14,758
- diarrhoea14,080
- rash12,975
- pneumonia11,607
- infusion related reaction11,393
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,590 |
| 2005 | 2,685 |
| 2006 | 3,150 |
| 2007 | 2,550 |
| 2008 | 3,882 |
| 2009 | 3,069 |
| 2010 | 3,843 |
| 2011 | 8,184 |
| 2012 | 8,165 |
| 2013 | 3,385 |
| 2014 | 4,018 |
| 2015 | 6,122 |
| 2016 | 8,307 |
| 2017 | 7,474 |
| 2018 | 9,223 |
| 2019 | 12,638 |
| 2020 | 19,805 |
| 2021 | 20,050 |
| 2022 | 27,215 |
| 2023 | 27,956 |
| 2024 | 28,660 |
| 2025 | 28,275 |
| 2026 | 20,022 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,792,880 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| infusion related reactionSignal | 11,393 | 16.5 | 16.2 | 137,797 |
| toxicity to various agentsSignal | 16,856 | 8.8 | 8.7 | 106,161 |
| pyrexiaSignal | 14,843 | 3.6 | 3.5 | 26,629 |
| pneumoniaSignal | 11,607 | 3.0 | 2.9 | 14,709 |
| arthralgiaSignal | 14,758 | 2.9 | 2.9 | 18,403 |
| vomitingSignal | 14,905 | 2.6 | 2.6 | 14,568 |
| painSignal | 18,805 | 2.5 | 2.5 | 17,066 |
| rashSignal | 12,975 | 2.4 | 2.4 | 10,912 |
| headacheSignal | 17,530 | 2.3 | 2.3 | 12,716 |
| fatigueSignal | 21,355 | 2.2 | 2.2 | 14,840 |
| dyspnoeaSignal | 15,395 | 2.2 | 2.2 | 10,347 |
| off label useSignal | 23,643 | 2.2 | 2.2 | 15,827 |
| nausea | 18,668 | 1.9 | 1.9 | 8,355 |
| diarrhoea | 14,080 | 1.8 | 1.7 | 4,785 |
| drug ineffective | 19,055 | 1.2 | 1.2 | 475 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.